Related Experiment Video
Updated: May 1, 2026
05:18
Measuring Carbon Content in Airway Macrophages Exposed to Carbon-Containing Particulate Matters
Published on: July 12, 2024
949
Dust events, pulmonary diseases and immune system
Nafiseh Esmaeil1, Marjan Gharagozloo2, Abbas Rezaei3
1Department of Immunology, School of Medicine, Isfahan University of Medical Sciences Isfahan, Iran ; Departmentof Environmental Medicine, New York University School of Medicine Tuxedo, New York, USA.
American Journal of Clinical and Experimental Immunology
|March 25, 2014
Summary
Increased sandstorms pose health risks, particularly pulmonary disease. Understanding the immune response to inhaled desert dust is crucial for developing effective treatments for respiratory illnesses.
Area of Science:
- Environmental Science
- Immunology
- Pulmonology
Background:
- Sandstorm frequency and long-distance dust transport are increasing.
- Inhaled desert dust triggers complex immune responses in the airways.
Purpose of the Study:
- To elucidate the cellular and molecular mechanisms of immune responses to inhaled desert dust.
- To identify potential therapeutic targets for desert dust-associated pulmonary diseases.
Main Methods:
- Review of current research on immune cell activation by dust particles.
- Analysis of immune pathways including T helper cells (Th1, Th2, Th17), T cytotoxic cells, and B cells.
- Emphasis on the need for epidemiological studies and dust composition analysis.
Main Results:
- Dust particles activate epithelial cells, macrophages, dendritic cells, and innate immune cells.
- Initiation of inflammatory responses involving various immune cell subsets and cytokine release.
- Pathological effects on the lung vary depending on the specific immune response.
Conclusions:
- Desert dust inhalation provokes significant pulmonary immune responses.
- Further research into precise immune mechanisms is essential for novel treatment strategies.
- Integrated epidemiological and mechanistic studies are needed for effective prevention and treatment.
Related Concept Videos
01:23Chronic Obstructive Pulmonary Disease I: Introduction
33
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
33
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
5.0K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
5.0K
01:17Other Pulmonary Disorders
1.8K
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
1.8K
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
40
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
40
01:28Asthma I: Introduction
112
Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
112
01:29Asthma-I: Introduction
3.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.6K